- Home
- HUIZ vs CURX Comparison
HUIZ vs CURX Comparison
Compare HUIZ & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUIZ | CURX |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 14.5M |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HUIZ | CURX |
|---|---|---|
| Price | $1.72 | $0.45 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.30 | N/A |
| AVG Volume (30 Days) | 99.2K | ★ 203.7K |
| Earning Date | 03-27-2026 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $0.26 |
| 52 Week High | $4.16 | $9.18 |
Technical Indicators
Market Signals| Indicator | HUIZ | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 51.29 | 48.54 |
| Support Level | $1.60 | $0.38 |
| Resistance Level | $2.12 | $0.53 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 87.39 | 25.64 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.